Advertisements



Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results.....»»

Category: topSource: seekingalphaJul 12th, 2018

Biotech Analysis Central Pharma News: Shire"s Results, Novo Nordisk"s Goal, Pfizer And Exact Team Up

Biotech Analysis Central Pharma News: Shire"s Results, Novo Nordisk"s Goal, Pfizer And Exact Team Up.....»»

Category: topSource: seekingalphaAug 28th, 2018

Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck"s Approvals, Bayer"s Green Light

Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck"s Approvals, Bayer"s Green Light.....»»

Category: topSource: seekingalphaSep 5th, 2018

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure.....»»

Category: topSource: seekingalphaAug 28th, 2018

Biotech Analysis Central Pharma News: Gilead"s Hope Dashed, Pfizer"s Vaccine Deal, Eisai And Merck FDA Approval

Biotech Analysis Central Pharma News: Gilead"s Hope Dashed, Pfizer"s Vaccine Deal, Eisai And Merck FDA Approval.....»»

Category: topSource: seekingalphaAug 20th, 2018

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio"s FDA Despair, Paratek"s Positive FDA Panel

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio"s FDA Despair, Paratek"s Positive FDA Panel.....»»

Category: topSource: seekingalphaAug 13th, 2018

Biotech Analysis Central Pharma News: Roche"s EMA Advance, Pfizer"s New Strategy, Arrowhead"s First Amgen Milestone Payment

Biotech Analysis Central Pharma News: Roche"s EMA Advance, Pfizer"s New Strategy, Arrowhead"s First Amgen Milestone Payment.....»»

Category: topSource: seekingalphaAug 6th, 2018

Biotech Analysis Central Pharma News: Teva"s U.S. Erosion, Denali"s Preliminary Results, Epizyme"s Trial Shutdown

Biotech Analysis Central Pharma News: Teva"s U.S. Erosion, Denali"s Preliminary Results, Epizyme"s Trial Shutdown.....»»

Category: topSource: seekingalphaAug 3rd, 2018

Biotech Analysis Central Pharma News: Merck"s HIV Results, Biogen"s Partnership, Eli Lilly"s $1 Billion Deal

Biotech Analysis Central Pharma News: Merck"s HIV Results, Biogen"s Partnership, Eli Lilly"s $1 Billion Deal.....»»

Category: topSource: seekingalphaJul 31st, 2018

Biotech Analysis Central Pharma News: Merck Notches A Win, resTORbio"s Positive Phase 2b, Abbvie"s Endometriosis Pain Drug Approval

Biotech Analysis Central Pharma News: Merck Notches A Win, resTORbio"s Positive Phase 2b, Abbvie"s Endometriosis Pain Drug Approval.....»»

Category: topSource: seekingalphaJul 28th, 2018

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure.....»»

Category: topSource: seekingalphaJun 6th, 2018

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA.....»»

Category: topSource: seekingalphaApr 24th, 2018

Biotech Analysis Central Pharma News: Allergan"s CRL, Tonix Pharmaceutical"s Potential Reversal, AstraZeneca"s Tagrisso Win

Biotech Analysis Central Pharma News: Allergan"s CRL, Tonix Pharmaceutical"s Potential Reversal, AstraZeneca"s Tagrisso Win.....»»

Category: topSource: seekingalphaAug 24th, 2018

Biotech Analysis Central Pharma News: Regeneron"s Reversal Of Fortune, Bristol-Myers Squibb"s FDA Win, Novo Nordisk"s Acquisition

Biotech Analysis Central Pharma News: Regeneron"s Reversal Of Fortune, Bristol-Myers Squibb"s FDA Win, Novo Nordisk"s Acquisition.....»»

Category: topSource: seekingalphaAug 20th, 2018

Biotech Analysis Central Pharma News: Roche Raises Guidance, Biogen"s Alzheimer Promise, GlaxoSmithKline"s Panel Vote

Biotech Analysis Central Pharma News: Roche Raises Guidance, Biogen"s Alzheimer Promise, GlaxoSmithKline"s Panel Vote.....»»

Category: topSource: seekingalphaJul 27th, 2018

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed.....»»

Category: topSource: seekingalphaJul 15th, 2018

Zogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatment

Zogenix Inc. shares soared about 19% in premarket trade Thursday, after the biotech reported positive results in a late-stage trial of a treatment for the severe form of epilepsy, Dravet syndrome, in children and yo.....»»

Category: topSource: marketwatchJul 12th, 2018

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data.....»»

Category: topSource: seekingalphaJul 10th, 2018

Biotech Analysis Central Pharma News: Puma"s Reversal Win, Pain Therapeutics Suffers Major Blow, Achaogen"s FDA Score

Biotech Analysis Central Pharma News: Puma"s Reversal Win, Pain Therapeutics Suffers Major Blow, Achaogen"s FDA Score.....»»

Category: topSource: seekingalphaJun 27th, 2018